ARTICLE | Company News
Vertex, Enterome Bioscience deal
May 2, 2016 7:00 AM UTC
Vertex granted Enterome exclusive, worldwide rights to small molecule antagonists of bacterial fimbrial adhesin (fimH), including lead compound EB 8018, to treat inflammatory bowel disease (IBD). En...